Videos & Webinars

Mental Wellness & Connection for Veterans with Parkinson's

Breaking the Silence: Mental Wellness & Connection for Veterans with Parkinson's

February 27, 2025

This program will bring awareness to the symptoms that are often unspoken among veterans with Parkinson’s. We will address the real impact of loneliness and isolation, offer strategies for managing post-traumatic stress disorder, and provide guidance on overcoming fears associated with symptoms. Explore resources and support options designed to relieve isolation and nurture meaningful connections.

Download Slides

Additional Resources

Presenter

Ellen Bradley, MD 
Assistant Professor, Department of Psychiatry and Behavioral Sciences 
Weill Institute for Neurosciences  

My PD Story

Craig Meurlin headshot
People with PD

Craig Meurlin

My father was diagnosed with Parkinson’s disease (PD) in the mid-to-late 90s and he lived with PD until his passing in 2012. I was diagnosed with PD in 2019, and I was quickly frustrated that I was being given the same drug for PD my father had used 30 years ago.  

It seemed an inordinately long time to not have progressed more with treatments and drugs. Certainly, there were some advances to treat Parkinson’s symptoms, like deep brain stimulation (DBS), but it all seemed to circle back to the primary PD drug carbidopa-levodopa

As I navigated this reality, and my Parkinson’s symptoms, I eventually connected with the Parkinson’s Foundation. I appreciated that the Foundation’s resources made clear that Parkinson’s is not just a movement disorder. Some neurologists I have dealt with don’t seem to care as much about the non-movement symptoms, and I have those in spades (and had them for a number of years before my actual PD diagnosis).  

Learning about how PD impacts so many systems in my body and how common these non-movement symptoms are through the Foundation has been helpful and is just one part of the personalized approach the Foundation does so wonderfully. That personalized approach is why I began to financially support the Foundation. 

What meaningfully differentiated the Parkinson’s Foundation from the other PD charities in my mind was when I learned about the Foundation’s Parkinson’s Virtual Biotech initiative. I truly became excited as it seemed to me to be an optimal approach to accelerate research on developing new treatment options as well as finding the cause of PD. The usual institutional approach has not seemed, to me at least, to have made the kind of progress needed, particularly considering the significant increase in the number of people being diagnosed with PD.  

Real, original research and development often occurs through the efforts of individuals who do not accept the status quo and believe enough in their own work to take the risks (and those risks are significant) of stepping out on their own to accelerate the development of their ideas. Things can get caught up in the bureaucracy of larger institutions (and, in some institutions, perhaps “group think”) that dampens both the creativity and speed of innovation needed for truly breakthrough developments.  

I was looking for something to support that was nimbler and led by people with real passion and belief in their own work, and I found it in the Parkinson’s Virtual Biotech initiative. The initiative’s combination of science and private entrepreneurialism is an excellent way to accelerate advances in applied research and development. Through this initiative, the Foundation makes venture capital investments in early-stage companies focused on PD research and development.   

Additionally, the Parkinson’s Virtual Biotech uses an investment model I am familiar with and have seen work successfully a number of times throughout my 40-year career as a corporate lawyer with a particular focus in securities law.  

I know the various stages of the venture capital process, the need to do significant technical due diligence and to properly evaluate a company’s management team to be comfortable with their ability to develop and follow through on a business plan to achieve the scientific and commercial objectives of the project.   

I like the fact that Parkinson’s Virtual Biotech investments in a company are made in stages based on the company’s achievement of certain milestones. The Parkinson’s Foundation and Parkinson’s UK have the resources to do that due diligence and keep the focus on Parkinson’s disease. They also mentor the management teams when necessary to assist in their success.  

I believe that through the Parkinson’s Virtual Biotech, the Parkinson’s Foundation can make a real difference in efforts to advance treatment options and ultimately cure Parkinson’s disease. Where else can you find the expertise (both in PD and in venture capital investments) found in the Parkinson’s Foundation and Parkinson’s UK, the access to many investment opportunities that are brought to this initiative and the management mentoring to move these projects forward?  I am unaware of other PD focused organizations doing this and it is something that I am very passionate about supporting it. 

I believe this model has the best chance to work for Parkinson’s and to make leaps of progress that are important if we hope to slow disease progression, eventually stop other people from getting it and finally learn what causes Parkinson’s disease. I would encourage anyone to join me in supporting the Parkinson’s Virtual Biotech initiative. 

Learn more about Parkinson’s Virtual Biotech and make a gift to support this exciting work. 

Educational Events

Navigating the Road Ahead: Understanding Driving and Parkinson’s

Virtual ( Zoom )
1:00 pm to 2:00 pm EST
FREE
Husband and wife lookin at a tablet while on their porch

Driving can symbolize freedom and independence, making decisions around driving a particularly sensitive subject for people living with Parkinson's disease. This webinar will address the complex considerations of driving with Parkinson's, including safety, self-assessment, and available resources. Participants will gain insights into how Parkinson's can impact driving skills, explore options for assessing driving abilities, and learn about practical approaches to planning for the future. Through expert guidance and real-life perspectives, this session aims to empower individuals and families to approach this topic with confidence, compassion, and informed decision-making.

Speaker

Margaret O'Connor, PhD, ABPP
Harvard Medical School

 

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends, and the community.

PD Health @ Home is presented by the Light of Day Foundation, whose generosity has made this programming possible.

Light of Day

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

Managing Changing Symptoms

11:00 am to 3:00 pm EST
FREE
Managing Changing Symptoms

After many years of good symptom management, Parkinson’s disease may become more challenging. Learn how Parkinson’s symptoms may change over time and new strategies available for managing them. 

Speakers

Stephen Lee, MD, PhD
Dartmouth Hitchcock Medical Center

Mary Feldman, DO
Dartmouth Hitchcock Medical Center

Anas Hannoun, MD
Dartmouth Hitchcock Medical Center

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends and the community.  

Registration is now closed as we have reached the venue capacity. We have opened registration to join the waitlist. If a spot becomes available, we will notify those on the waitlist.

Agenda (Eastern Time)

Gold Sponsor

Upcoming Events

Advancing Research

PD GENEration: Advancing Research, Empowering Lives

PD GENEration map of U.S.

PD GENEration: Mapping the Future of Parkinson’s Disease is an international Parkinson’s Foundation research study that has enrolled more than 20,000 people with Parkinson’s disease (PD) since its launch six years ago. Study data has already led to eye-opening insights into the disease, such as determining a more precise range of 12-13% of people with PD having a genetic link to the disease — significantly more accurate than the previously estimated 5-10% average prevalence.

As PD GENEration continues to expand, the Parkinson’s Foundation remains dedicated to its core mission of educating people with Parkinson’s. The Foundation held a live webinar to share what we’ve learned from PD GENEration so far and where the study may be headed. Joining the study team speakers were two PD GENEration participants who spoke about their experiences. This webinar offered PD GENEration participants and their families the opportunity to ask questions of the study team.   

The following article is based on the Parkinson’s Foundation webinar PD GENEration: Advancing Research, Empowering Lives, hosted on January 21, 2025 by James Beck, PhD, Chief Scientific Officer, with guests Roy Alcalay, MD, PD GENEration Principal Investigator, Vanessa Russell-Palmer, Parkinson’s Foundation Research Advocate, and Lisa Kirk, PD GENEration participant.

Watch the full webinar recording now

Previous Genetic Testing Studies Did Not Share Testing Results with Participants

A scientific focus on the genetic risk factors that influence PD is a relatively recent development for the PD research field, which has only gained momentum since the discovery of the first PD-related gene in the 1990s. Since then, more clinical studies began to include genetic testing as a part of their research protocols.

However, the genetic information collected in these studies was not shared with participants, sometimes putting researchers in difficult situations where they identified genetic risk factors but could not let participants know due to trial protocols. Many studies did not include genetic counseling where a trained and licensed counselor reveals and explains test results.

This left many of the people living with PD who were involved in these trials unaware of their PD genetic risk factors. Many then missed opportunities to join future clinical trials centered on their genetic variant, slowing down the progress of PD research for those populations.

“You cannot undo knowledge. If you’re telling someone that they carry a mutation, we cannot take it back,” said Dr. Alcalay. Thus, a hallmark of PD GENEration is to deliver the potential life-changing genetic test results with care and consideration through certified genetic counselors at no-cost to study participants.

PD GENEration Begins: From Pilot Study to Soaring Engagement

In late 2019, the Parkinson’s Foundation launched PD GENEration, which was designed to be accessible to all people with a confirmed Parkinson’s diagnosis. This open approach was in contrast to many previous PD genetics studies, which often limited participation to specific populations. The PD GENEration genetic panel focuses on seven of the most common variants in PD-related genes, all of which are widely recognized as relevant in PD research fields.

In response to COVID-19 precautions in the study’s early years, PD GENEration quickly evolved, providing the ability for people to join the study through an at-home test kit or in-person at a clinical study site.

PD GENEration: Powered by the Parkinson's Foundation

In the next few years, PD GENEration grew its study population with ever-increasing momentum as more healthcare sites and genetic counselors were brought on board across the country. In March 2024, the total participant count reached 15,000, a significant milestone that encouraged a new phase of expansion.

PD GENEration evolved in two ways:

  1. The first was the launch of new initiatives to reach and encourage enrollment in PD communities from non-European populations, from where >90% of genetic testing has focused. This expansion recognizes that Parkinson’s is a complicated disease, and therefore working to increase the diversity of genetic data being collected is crucial to offer insights and potential for breakthrough discoveries impacting the global PD community. One way this was achieved was to expand the study to Latin America in collaboration with The Latin American Research Consortium on the Genetics of Parkinson’s Disease (LARGE-PD), focused on increasing PD knowledge in these countries.
  2. The second was PD GENEration expanded was to extend the genetic testing panel itself. Today, in addition to the seven genes related to PD, 21 additional PD-associated genes can be reported back to the participant if they so choose. This panel extension provides valuable data toward understanding the impact these less-well understood mutations may have on PD onset and progression. Not only that, but participants can now also elect to receive results regarding 10 gene variants with a known link to hereditary cancer and heart disease. These results offer additional personal biological insights without an additional sample. Importantly, these disease states also have therapeutic interventions available, which may be of value to those who did not previously know their genetic risk.

A goal of PD GENEration is to accelerate PD research. The Parkinson’s Foundation is doing just that by vastly expanding the amount of genetic data available for analysis. To obtain the necessary amount of DNA for analysis, PD GENEration pivoted from saliva-based sample collection to blood-based. Thanks to the innovative Tasso+ device, which allows for quick at-home blood sample collection in a safe and comfortable way, people can continue to join the study remotely while also ensuring they can fully contribute to advancing PD research.

More than Just Data: Knowledge as Empowerment

Since the beginning, PD GENEration’s goal has been to make genetic testing accessible to everyone living with Parkinson’s. In doing so, the study not only collects and shares valuable data with the PD research community in search of treatment breakthroughs but also empowers participants with a greater understanding of their unique disease journey.

Lisa Kirk, a former search-and-rescue canine handler, remembers the shock of learning that her early symptoms were not just aging-related. “It never occurred to me that it was Parkinson's. I thought at the most I had essential tremors. When I did get the diagnosis, it was one of those moments when you remember every detail. You remember the weather, what you were wearing, who was with you. It was a shock.”

Over time, as Lisa better understood how to manage her PD symptoms, she began searching for ways to participate to PD research.

“Whatever treatment I received was because someone else, another patient with Parkinson’s, had participated in a study of some kind. I wanted to help make a difference for other people. That was what motivated me to participate in the PD GENEration study.”

- Lisa Kirk, PD GENEration participant

For Vanessa Palmer, her diagnosis came after an orthopedic injury. “I noticed on my right side in my hand, it felt like I had a tremor, but when I looked I couldn’t see any movement. My orthopedic doctor just thought I had a lot of sciatic nerve damage and said ‘We’ll just watch it’. But by the end of 2015, I had a true resting tremor.”

Eventually she found a neurologist who ran some tests. “The neurologist asked me ‘Did you bring anyone with you?’ I said no, I’m on my lunch hour, and she said ‘Well, I think you have early-onset Parkinson’s disease. And it just took the wind out of me.” A second opinion at a movement disorders clinic confirmed Vanessa’s PD diagnosis.

Her first few years of living with PD Vanessa was in survival mode. “Just taking my meds, hoping they’re working and just trying to survive.” One day her doctor asked if she wanted to participate in research. She said yes “because at this point, I wanted to do something to contribute or fight back. The first thing she presented to me was PD GENEration.” Having no family history of PD, Vanessa was interested to better understand the cause of her diagnoses.

The genetic results and counseling provided to Lisa and Vanessa had their share of surprises. Lisa learned that she had the GBA1 mutation, the most common PD risk factor. “That’s when I realized I needed to talk to my family and tell them that hereditary PD is a possibility. I understand that most people with this mutation never get Parkinson’s, but some do so I wanted to give my family a heads up,” Lisa said.

The unexpected result related to Lisa’s ancestry. Lisa believed that her family history was based in northern Europe, but from the genetic testing she learned that her genealogy is primarily French with an Ashkenazi background, a genetic heritage linked to greater risk for PD. “All of these things were grounding,” Lisa says, “It actually helped me feel like I have a better understanding of who I am and my role in Parkinson’s.”

Vanessa’s results revealed that she did not have a genetic tie to PD. “At least I know, and I’m not worried about my children and my grandchildren to come,” she said. While the results may not have helped explain Vanessa’s diagnosis, they still help researchers look for new undiscovered causes or risk factors for PD, which “helped me feel better, and I wanted to help other people feel better, and [as an African American] I wanted to help get more diversity in the database.” Vanessa would go on to become a Parkinson’s Foundation Research Advocate in 2023, and continues to support her PD community through outreach, information sharing, and empowerment.

The Future of PD GENEration

PD GENEration continues to grow at an inspiring pace, in large part due to generous support from groups including the Global Parkinson’s Genetics Program (GP2), a program of the Aligning Sciences Across Parkinson’s (ASAP) initiative.

This support allows the study to reach more people with PD as well as increase the pace of genetic knowledge gained and provide back to those who join. As the study advances, the Parkinson’s Foundation seeks to answer questions including:

  • Can genetic information predict if deep brain stimulation (DBS) would be an effective treatment?
  • How do genetic risk factors and environmental risk factors interact in PD development and progression?
  • What underlies the asymmetric nature of PD (e.g. why might tremors develop on one side of the body instead of the other)?
  • What explains a family history of PD where none of the family members test positive for the seven main genetic risk factors?

As the study progresses, driven by collaboration between researchers, clinicians and the PD community, PD GENEration is confident that it can help contribute the data and knowledge to help answer these and many other questions.

There is still so much more to understand about Parkinson’s, but the continued success and support of PD GENEration is undoubtedly helping the science behind PD and the community move forward, together.

Learn more about PD GENEration and how you can enroll today.

Educational Events

New England Chapter Parkinson’s Symposium

Virtual ( Zoom )
10:00 am to 2:30 pm EST
FREE
2025 New England Symposium

Join the Parkinson’s Foundation [in person or online] for the New England Chapter Parkinson’s Symposium. Hear about current and upcoming treatments, ongoing research, and resources available in your community to help you live your best life with Parkinson’s. 

Speakers:

Joy Antonelle de Marcaida, MD
Hartford HealthCare

Anna DePold Hohler, MD, FAAN
St. Elizabeth’s/Boston Medical Center Health System

David K. Simon, MD, PhD
Beth Israel Deaconess Medical Center

Anas Hannoun, MD
Dartmouth Hitchcock Medical Center

Agenda (Eastern Time)

Gold Sponsor

More to Parkinson's

Upcoming Events

My PD Story

Bob Regan posing for a picture with a guitar
People with PD

Bob Regan

The Word

All who cross over into the land of the afflicted have one. A word. A sentence. A fate. Mine? Parkinson’s, the P word. It arises unbidden as I walk, my left leg not quite keeping pace with my right. It floats to top of mind when my tremor flares in a social setting, again when I realize I am not speaking loudly enough in conversation. Parkinson’s. Parkinson’s. Parkinson’s. I’m sick of it and I’m sick from it, the word and its confederates: neurological, progressive, incurable. 

I was first bestowed the word on an otherwise unremarkable day. I arrived at my initial appointment with the neurologist assuming I would receive confirmation of my primary doc’s best-guess diagnosis of an “Essential Tremor” — relatively benign. We had a brief conversation, she had me perform some dexterity tests, observed me walking up and down the hallway, then asked if I had ever acted out dreams, punching, kicking, or yelling while asleep. I had not.  

She then abruptly said, “Your symptoms are consistent with Parkinsonism.” What? What did that even mean? Was she trying to say the P word without saying it? I asked her point blank. Her answer? A slight head nod and a “Yes.” At that pivot point, everything reeled and the tectonic plates at my core shifted and fractured. I now had a word, my word, one that will loop in my misfiring neural synapses for the remainder of my days. 

I sometimes wonder what previously occupied all the psychic space now hogged by the P word? An entirely unrealistic assumption that I would always enjoy good health? A smug satisfaction that I was in better health than many of my peers? An underlying sense of physical well-being?  

All those foundational articles of belief vaporized upon my diagnosis.   

I remind myself that I am fortunate to be in the early stages of the P word and still able to do most of the things I enjoy and I am fully aware that there are many with far more daunting conditions than mine. I give myself pep talks: “Don’t be defined by your diagnosis,” and “Keep fighting,” Good advice, certainly, but alacrity and stoicism are lofty, cerebral concepts, flimsy and flaccid weapons in the face of my relentless adversary. The P word, too, is cerebral, but it does its dirty business on a deeper, more primal level, the substantia nigra, those words conjuring a devouring black hole in my cranial universe. Clint Eastwood’s admonition to “Not let the old man in,” is good in theory but the “old man” arrived unannounced and had set up shop before I even knew he was here. 

There are surgical interventions but I am told I am not yet a candidate and that I won’t be until my symptoms worsen. Finally! Something to look forward to! (Insert sarcasm emoji here.) Meanwhile, well-intentioned friends refer me to articles touting potential breakthroughs, even cures. They shimmer like cool water in the distance on my parched P word path. I can only hope they do not turn out to be to be mirages. 

How to proceed? With denial, with exercise, with deflection, with exercise, and finally, with more exercise which I am told can slow the progression of my symptoms. My gallows humor, always at the ready, is asserting itself more now that the actual gallows are in sight. I should note here that the P word is not a death sentence, rather a life sentence. I’m told I will likely die with it, not from it. 

Given that, there is good reason to think I might stick around to enjoy more springs, more summers, more falls, which have taken on a metaphoric poignancy and, yes, winters, even as I come to inhabit my own. And one day, tremors, shuffling gait, and all, I might see my 90th birthday, attend my grandchildren’s graduations, and even welcome great-grandchildren into the world. Who knows? It could happen. Maybe my new P word should be “persevere.” 

This My PD Story was originally published in The Boston Globe’s Ideas section. Bob Regan is a songwriter in Nashville, TN. 

Learn more about Living with Parkinson’s and explore Parkinson’s Foundation Resources today.  

My PD Story

Julie Obreiter selfie
People with PD

Julie Obreiter

My name is Julie, and I was diagnosed with young-onset Parkinson’s disease (YOPD) in 2018 at the age of 44. Since my diagnosis, my most prominent symptoms have been rigidity, slowness of movement, and foot dystonia.  

Part of my PD journey involves a scary hospital experience in 2023. While my daughter and I were on a cross-country road trip together I began experiencing severe dyskinesia (involuntary, erratic, writhing movements of the face, arms, legs or trunk) and cramping. This is fairly common for me, and sometimes, when this happens, I use THC (medical marijuana) to find relief.  

However, when I did this time, I became unresponsive, which had never happened before. My daughter pulled over to call 911 and an ambulance transported me to the hospital. 

The next thing I knew, I woke up in the ER. I thought I was having a bad dream. My daughter explained to the medical team that I have Parkinson’s, and like many others, use THC to help manage my symptoms.  

The ER team was convinced I was a drug addict and treated me like I had done something wrong. My daughter and I were both shocked and scared. They didn’t believe I had Parkinson’s, and they refused to perform any tests or allow me to take my Parkinson’s medications. 

Unfortunately, it took several hours to convince the medical team that my Parkinson’s medications were essential. Once they realized these weren’t street drugs, my medications were administered, and my symptoms became under control.  

The doctor neglected to contact my neurologist, and further testing was never done. I was treated carelessly and discharged the same day. When I talked with my neurologist after the hospitalization, he said that I experienced a “dystonic storm.”  

Since then, I have taken time to process this traumatic experience and learned how to advocate for myself as a person with Parkinson’s. Most recently, I underwent deep brain stimulation (DBS) surgery that changed my life — and greatly improved my symptoms.  

While we don’t always know when we are headed for a hospital stay or ER visit, there are ways to prepare. The Parkinson’s Foundation Hospital Safety Guide can help you and your loved ones prepare before your next planned or unplanned hospital visit so that you feel prepared to navigate the hospital with confidence. 

Advocate for your best care with the Hospital Safety Guide. Learn more and download the guide now

My PD Story

Karen Rosenbaum posing in front of a field of flowers
People with PD

Karen Rosenbaum

My name is Karen, I am 58 years old, and I was diagnosed Parkinson’s disease (PD) in 2019, right before the global Covid-19 pandemic. At the point of my diagnosis, I was experiencing advanced symptoms that were previously masked by a busy life of motherhood and exercise. I attributed many of my symptoms, such as back stiffness and shaking, to overtraining, excessive caffeine and stress. I never thought an active person like me might develop Parkinson’s. 

Upon my diagnosis, I connected with a wonderful neurologist who determined that my Parkinson’s was caused by genetics. Unfortunately, over the course of several months, I began to experience severe symptoms of dystonia (repetitive muscle twisting, spasm or cramp), falling and stiffness on the left side of my body. My Parkinson’s medications help, but to this day, I still experience severe symptoms, which can be troubling to my loved ones as my medication wears off.  

As a result of Parkinson’s disease, I have found myself in many Emergency Room (ER) situations. I am a “clock watcher” when it comes to taking my medications on time, meaning that I take them frequently, every day, at the same exact time. Dystonia and stiffness hit me with a deep and painful heaviness, which is why I must stick to a strict medication schedule.  

Last fall, my neurologist believed I was a good candidate for a new extended-release Parkinson’s medication to alleviate my worst symptoms, which I eagerly agreed to try. After taking it for the first time, I quickly realized something was not right — my throat began to close due to severe dystonia, and my speech became increasingly slurred.  

I called my neighbor for help, and they quickly called an ambulance to transport me to the ER. I brought all my old Parkinson’s medications and everything else I might need for a hospital stay. I was having a bad reaction to the new medication.  

Unfortunately, things became a fiasco when the ER did not give me my medication on time. I was admitted to the hospital for observation overnight due to low blood pressure, and the medical team refused to give me my Parkinson’s medications.  

Between the ER and Admitting, hospital error of staff and pharmacy miscommunicated my list of medications in their computer system. I had clearly provided them a list of my medications and the schedule, yet they did not enter them into their computer system correctly. The inpatient nurse locked my medications from home in a drawer. It took me multiple attempts and worsening symptoms to convince the medical team to administer my medications.  

Many medication doses were missed and then given delayed 12 hours. When I finally left the hospital, my symptoms were significantly worse than before my hospital stay. Months later, I am still recovering.  

I share my story not to frighten anyone, but to encourage people with Parkinson’s and their loved ones to advocate for themselves while in the hospital. Medical teams are not always educated on the PD or Parkinson’s medications timing and care, and this can be a scary reality when you are alone.  

Lack of awareness in the hospital setting exists for how Parkinson’s presents itself in younger people. My story is an example of not judging a book by its cover. The Parkinson’s Foundation Hospital Safety Guide is designed to equip you for your next hospital stay. 

Advocate for your best care with the Hospital Safety Guide. Learn more and download the guide now

Raise Awareness

Meet Four People Walking, Running and Riding Toward a Cure

Group at Moving Day walk

In 2024, Moving Day, A Walk for Parkinson’s, Parkinson’s Revolution and Parkinson’s Champions raised $8.3 million to advance Parkinson’s disease (PD) research, improve access to care and connect people with PD and their loved ones to life-changing resources and support. 

These fundraisers and volunteers inspire us as they passionately spread Parkinson’s awareness and make Parkinson’s Foundation events a success. Meet Cindy, Hailey, Peggy and more community members who help us move toward a cure:

Cindy George

Cindy Builds Community Through Caregiving

Cindy George set out to learn as much as she could about Parkinson’s disease after her husband, Dale, was diagnosed 13 years ago. Together, they have grown their local PD community by starting a support group, participating in Moving Day Salt Lake City and more.

“People with Parkinson’s are superheroes who deserve to be recognized, and that’s what happens at Moving Day. It highlights the importance of exercise for people with Parkinson’s and provides so much education and information.”

KEEP READING


Hailey Harn's group at Revolution ride

Hailey Honors Dad, Rallies Friends through Parkinson’s Revolution

After her dad was diagnosed with PD, Hailey Harn wanted to wanted to find a positive and productive way to channel her energy toward a mission that would make an impact. She was touched when friends and other members of her community wanted to make an impact alongside her.

“Friends enthusiastically joined my team to raise money through Parkinson’s Revolution — we all realized PD touches far more people than we thought. With each donation came a story of a relative, colleague or friend who also had a connection to PD, and gratitude for working toward PD education, care and a cure!”

KEEP READING


Peggy Faber running a race

Peggy Completes 50 Marathons in 50 States to Raise Parkinson’s Awareness

Peggy was halfway to her goal of completing 50 marathons in 50 states when she was diagnosed with Parkinson’s. She didn’t let this deter her, and finished her final marathon as a part of Parkinson’s Champions on September 24, 2024.

“I found out during a race, around mile 20 when my gait and balance started to suffer, that I was going to have to work harder to make this goal happen with Parkinson’s. Other concerned racers asked if I needed help or medical attention. I thanked them for their concern and said, ‘This is what Parkinson’s looks like; help us find a cure.’”

KEEP READING


Piedmont Community Walk

Piedmont Fayetteville Unites Parkinson’s Community with First Community Walk

When Evan M. Johnson, MD, MSc, joined Piedmont Fayette Hospital in Fayetteville, GA, as a movement disorders specialist, he told his team his goal was to reach as many people as possible to support those with Parkinson’s and educate others. Organizing a Moving Day Community Walk for Fayetteville allowed them to unite their community and raise almost four times their fundraising goal.

“Community events like this are special moments to recognize and celebrate all individuals who are connected to Parkinson’s. Doing so helps reinforce to patients that they are not alone but are a part of a large community of peers and support.”

KEEP READING 

Read the Publication Now

DOWNLOAD THE PDF

Back to Top